Skip to Main Content

Advertisement

Skip Nav Destination

Abstract P1-18-37: Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 and 6i for HR+, HER2- MBC in the real world

Cancer Res (2022) 82 (4_Supplement): P1-18-37.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal